HCW Biologics is trading 5.1% up at $3.31, extending a sharp two-day surge that began after the company priced a $1.6 million private placement at $2.585 per unit.

  • The stock jumped 22.09% on July 30, 2026, as investors reacted to the capital raise and improved liquidity position.
  • Shares are maintaining upward momentum today, further supported by a broadly stronger biotechnology sector.